haloperidol and guanosine 5'-o-(3-thiotriphosphate)

haloperidol has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (33.33)18.2507
2000's13 (54.17)29.6817
2010's3 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elazar, Z; Fuchs, S1
Gardner, B; Strange, PG1
Bernard, A; Cavegn, C; Chabert, C; Mills, A1
Mohell, N1
Audinot, V; Cussac, D; Gobert, A; Lavielle, G; Lejeune, F; Millan, MJ; Muller, O; Newman-Tancredi, A; Nicolas, JP; Rivet, JM1
Kaplan, GB; Keith, DJ; Leite-Morris, KA1
Geurts, M; Hermans, E; Maloteaux, JM1
Dun, NJ; Hwang, BH; Mizoguchi, H; Nagase, H; Narita, M; Oji, DE; Tseng, LF1
Alper, RH; Gilliland, SL; Levant, B1
Hong, W; Werling, LL1
Hong, W; Werling, L1
Colpaert, FC; Pauwels, PJ; Tardif, S; Wurch, T1
Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L1
Bauzon, D; Bymaster, FP; Cohen, ML; DeLapp, NW; Falcone, JF; Kennedy, JS; Schenck, K1
Allouard, N; Alonso, R; Brun, P; Claustre, Y; Damoiseau, G; Françon, D; George, P; Gueudet, C; Lourdelet, J; Oblin, A; Peretti, DD; Scatton, B; Schoemaker, H; Sevrin, M; Soubrié, P; Steinberg, R; Suaud-Chagny, MF1
Assié, MB; Barret-Grévoz, C; Cosi, C; Kleven, MS; Newman-Tancredi, A1
Andersson, M; Fuxe, K; Strömberg, I; Terasmaa, A1
Assié, MB; Carilla-Durand, E; Cosi, C; Leduc, N; Maraval, M; Newman-Tancredi, A; Ormiere, AM1
Artaiz, I; Castro, E; Del Olmo, E; Innerárity, A; Labeaga, L; Orjales, A; Pazos, A; Zazpe, A1
Arrang, JM; Gbahou, F; Humbert-Claude, M; Morisset, S1
Burston, JJ; Howard, DR; Kendler, SH; Selley, DE; Sim-Selley, LJ; Wiley, JL1
Calas, AG; Goursaud, S; Hermans, E; Jeanjean, AP; Koener, B; Maloteaux, JM; Van De Stadt, M1
Chesterfield, AK; Felder, CC; Knitowski, KM; McKinzie, DL; Quets, AT; Rorick-Kehn, L; Shaw, DB; Watt, ML1
Barreiro, EJ; Bosier, B; Fraga, CA; Hermans, E; Menegatti, R; Monteiro do Monte, F; Noël, F; Pompeu, TE1

Other Studies

24 other study(ies) available for haloperidol and guanosine 5'-o-(3-thiotriphosphate)

ArticleYear
Vanadate inhibits agonist binding to D2 dopamine receptor.
    Journal of molecular neuroscience : MN, 1991, Volume: 3, Issue:1

    Topics: Animals; Apomorphine; Binding, Competitive; Cattle; Cell Membrane; Corpus Striatum; Dopamine Agents; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Kinetics; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Vanadates

1991
Pharmacological characterisation of high affinity [35S]GTP gamma S binding in membranes from CHO-K1 cells stably expressing rat D2(short) dopamine receptors.
    Biochemical Society transactions, 1995, Volume: 23, Issue:1

    Topics: Animals; Butaclamol; Cell Membrane; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Kinetics; Rats; Receptors, Dopamine D2; Recombinant Proteins; Spiperone; Stereoisomerism; Sulfur Radioisotopes

1995
Characterization of the functional activity of dopamine ligands at human recombinant dopamine D4 receptors.
    Journal of neurochemistry, 1994, Volume: 63, Issue:1

    Topics: Animals; Cell Line; Clozapine; DNA; Dopamine; Dopamine Agents; Ergolines; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Ligands; Moths; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone; Sulfur Radioisotopes; Tritium

1994
Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:1

    Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Mice; Pertussis Toxin; Quinpirole; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Tetrahydronaphthalenes; Virulence Factors, Bordetella

1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison w
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:3

    Topics: Animals; Antipsychotic Agents; CHO Cells; Clozapine; Cricetinae; Dopamine; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Male; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists

1998
Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins.
    Neuroscience letters, 1999, Oct-08, Volume: 273, Issue:3

    Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Corpus Striatum; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Mice; Olanzapine; Pirenzepine

1999
Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
    European journal of pharmacology, 1999, Oct-08, Volume: 382, Issue:2

    Topics: Animals; Apomorphine; Binding, Competitive; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Sulfur Radioisotopes; Tritium; Up-Regulation

1999
Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
    British journal of pharmacology, 1999, Volume: 128, Issue:6

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Atropine; Autoradiography; Baclofen; Binding, Competitive; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Haloperidol; Immunohistochemistry; In Vitro Techniques; Male; Membranes; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Opioid Peptides; Peptide Fragments; Propranolol; Receptors, Opioid; Somatostatin; Spinal Cord; Sulfur Radioisotopes; Yohimbine

1999
Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile.
    European journal of pharmacology, 2000, Mar-31, Volume: 392, Issue:3

    Topics: Animals; Benzazepines; Binding, Competitive; Clorgyline; Clozapine; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Membranes; Monoamine Oxidase Inhibitors; Quinpirole; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Selegiline; Spiperone; Sulfur Radioisotopes; Thiazoles

2000
Evidence that the sigma(1) receptor is not directly coupled to G proteins.
    European journal of pharmacology, 2000, Nov-17, Volume: 408, Issue:2

    Topics: Animals; Cerebellum; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Haloperidol; Liver; Male; Pentazocine; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor

2000
Lack of effects by sigma ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum.
    Brain research, 2001, May-18, Volume: 901, Issue:1-2

    Topics: Analgesics; Animals; Cell Membrane; Cerebellum; Cyclohexylamines; Dopamine Antagonists; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Hippocampus; Ligands; Male; Neuropeptide Y; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, sigma; Subcellular Fractions; Sulfur Radioisotopes

2001
Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
    British journal of pharmacology, 2001, Volume: 134, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alternative Splicing; Animals; Binding, Competitive; Butaclamol; Calcium; CHO Cells; Clozapine; Cricetinae; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Genotype; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Lisuride; Mutation; Plasmids; Receptors, Dopamine; Receptors, Dopamine D2; Recombinant Proteins; Sulfur Radioisotopes; Time Factors

2001
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
    European journal of pharmacology, 2001, Oct-05, Volume: 428, Issue:2

    Topics: Animals; Antipsychotic Agents; Binding, Competitive; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Membranes; Piperazines; Piperidines; Pyridines; Pyrimidinones; Pyrrolidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Thiazoles; Thioridazine; Tritium

2001
Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine.
    European journal of pharmacology, 2001, Nov-02, Volume: 430, Issue:2-3

    Topics: Animals; Benzodiazepines; Binding, Competitive; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Haloperidol; HeLa Cells; Humans; Ileum; In Vitro Techniques; Indoles; Lysergic Acid; Muscle Contraction; Olanzapine; Ondansetron; Pirenzepine; Quetiapine Fumarate; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfur Radioisotopes; Tritium; Tropisetron

2001
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:12

    Topics: 5-Hydroxytryptophan; Action Potentials; Animals; Antipsychotic Agents; Behavior, Animal; Binding Sites; Brain; Cell Count; Dioxanes; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Electrochemistry; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Immunohistochemistry; In Vitro Techniques; Levodopa; Male; Microdialysis; Neurons; Piperazines; Proto-Oncogene Proteins c-fos; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Sulfur Isotopes; Time Factors; Tropanes

2003
Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
    Psychopharmacology, 2005, Volume: 177, Issue:4

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Catalepsy; Dopamine Antagonists; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Piperazines; Posture; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Serotonin Receptor Agonists

2005
Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
    Journal of neuroscience research, 2005, Oct-15, Volume: 82, Issue:2

    Topics: Analgesics; Animals; Basal Ganglia; Binding, Competitive; Cyclohexanols; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Up-Regulation

2005
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    European journal of pharmacology, 2006, Mar-27, Volume: 535, Issue:1-3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Binding, Competitive; Cell Line; Clozapine; Dioxanes; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Male; Piperazines; Prolactin; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Spodoptera; Sulfur Radioisotopes; Tropanes

2006
In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Neuropharmacology, 2006, Volume: 51, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Avoidance Learning; Binding, Competitive; Catalepsy; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Head Movements; Hypothermia; Jaw; Male; Mice; Motor Activity; Piperazines; Pyridazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Tremor

2006
Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
    Biochemical pharmacology, 2007, Apr-15, Volume: 73, Issue:8

    Topics: Animals; Corpus Striatum; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Imidazoles; Male; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Histamine H3; Sulfur Radioisotopes

2007
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
    Neuropharmacology, 2008, Volume: 55, Issue:7

    Topics: Aging; Animals; Antipsychotic Agents; Cells, Cultured; CHO Cells; Clozapine; Cricetinae; Cricetulus; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Dronabinol; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Sex Characteristics; Signal Transduction

2008
Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 383, Issue:1

    Topics: Animals; Apomorphine; Aripiprazole; Buffers; Catalepsy; Cell Membrane; Cerebral Cortex; Corpus Striatum; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Antagonism; Drug Partial Agonism; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Hippocampus; Male; Piperazines; Piperidines; Pyridines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Stereotyped Behavior; Up-Regulation

2011
The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:13

    Topics: Analysis of Variance; Animals; Antipsychotic Agents; Avoidance Learning; CHO Cells; Conditioning, Operant; Cricetulus; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Binding; Receptor, Muscarinic M2; Receptor, Muscarinic M4; Tropanes

2013
Partial agonism and fast dissociation of LASSBio-579 at dopamine D2 receptor.
    Progress in neuro-psychopharmacology & biological psychiatry, 2015, Oct-01, Volume: 62

    Topics: Antipsychotic Agents; Aripiprazole; Cell Membrane; Clozapine; Corpus Striatum; Dopamine Agonists; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; HEK293 Cells; Humans; Kinetics; Piperazines; Radioligand Assay; Receptors, Dopamine D2; Transfection

2015